Table of Content

1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS & EXCLUSIONS 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
1.3.2 YEARS CONSIDERED 35
1.3.3 CURRENCY CONSIDERED 35
1.4 STAKEHOLDERS 36
1.5 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
2.1.1 SECONDARY DATA 39
2.1.1.1 Key data from secondary sources 41
2.1.2 PRIMARY DATA 41
2.1.2.1 Key data from primary sources 43
2.1.2.2 Key industry insights 44
2.2 MARKET SIZE ESTIMATION 45
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 49
2.4 MARKET RANKING ANALYSIS 50
2.5 STUDY ASSUMPTIONS 51
2.6 RISK ASSESSMENT 51
2.7 LIMITATIONS 51
2.7.1 METHODOLOGY-RELATED LIMITATIONS 51
3 EXECUTIVE SUMMARY 52
4 PREMIUM INSIGHTS 56
4.1 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET OVERVIEW 56
4.2 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE AND REGION (2023) 57
4.3 GEOGRAPHIC SNAPSHOT OF GASTROENTEROLOGY/GASTROINTESTINAL
PRODUCTS MARKET 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
5.2.1 DRIVERS 60
5.2.1.1 Rising prevalence of GI disorders 60
5.2.1.2 Technological advancements in gastroenterology products 60
5.2.1.3 Growing aging population 61
5.2.2 RESTRAINTS 62
5.2.2.1 Stringent regulatory policies for GI products 62
5.2.2.2 Increasing healthcare costs 62
5.2.2.3 Unfavorable healthcare reforms in US 64
5.2.3 OPPORTUNITIES 64
5.2.3.1 Increasing preference for minimally invasive surgery 64
5.2.4 CHALLENGES 65
5.2.4.1 Changing regulatory landscape 65
5.2.4.2 Shortage of trained physicians and endoscopists 65
5.3 INDUSTRY TRENDS 66
5.4 TECHNOLOGY ANALYSIS 66
5.4.1 KEY TECHNOLOGIES 66
5.4.1.1 Capsule endoscopy 66
5.4.2 COMPLEMENTARY TECHNOLOGIES 67
5.4.2.1 Laboratory testing 67
5.4.3 ADJACENT TECHNOLOGIES 67
5.4.3.1 Robotic surgery systems 67
5.5 VALUE CHAIN ANALYSIS 68
5.6 PORTER’S FIVE FORCE ANALYSIS 69
5.6.1 THREAT OF NEW ENTRANTS 70
5.6.2 THREAT OF SUBSTITUTES 70
5.6.3 BARGAINING POWER OF SUPPLIERS 70
5.6.4 BARGAINING POWER OF BUYERS 70
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 70
5.7 REGULATORY LANDSCAPE 71
5.7.1 REGULATORY ANALYSIS 71
5.7.1.1 North America 71
5.7.1.1.1 US 71
5.7.1.1.2 Canada 72
5.7.1.2 Europe 72
5.7.1.3 Asia Pacific 72
5.7.1.3.1 Japan 72
5.7.1.3.2 China 73
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
5.8 PATENT ANALYSIS 76
5.8.1 PATENT PUBLICATION TRENDS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS 76
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 77
?
5.9 TRADE ANALYSIS 78
5.9.1 HS CODES: GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS 78
5.9.2 IMPORT DATA 79
5.9.3 EXPORT DATA 79
5.10 PRICING ANALYSIS 80
5.11 REIMBURSEMENT ANALYSIS 81
5.12 KEY CONFERENCES & EVENTS, 2024–2025 83
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 84
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
5.13.2 BUYING CRITERIA 85
5.14 UNMET NEEDS ANALYSIS 86
5.15 END-USER EXPECTATIONS 87
5.16 ECOSYSTEM ANALYSIS 88
5.17 CASE STUDY ANALYSIS 89
5.18 SUPPLY CHAIN ANALYSIS 89
5.19 INVESTMENT & FUNDING SCENARIO 91
5.20 IMPACT OF GEN AI/AI ON GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET 91
6 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE 94
6.1 INTRODUCTION 95
6.2 ENDOSCOPY DEVICES 96
6.2.1 FLEXIBLE ENDOSCOPES 98
6.2.1.1 Advantages such as flexibility and ease of use to drive demand for flexible endoscopes 98
6.2.2 RIGID ENDOSCOPES 99
6.2.2.1 Ability of rigid endoscopes to provide vertical-axis images of internal organs to support market growth 99
6.2.3 CAPSULE ENDOSCOPES 100
6.2.3.1 Non-invasive nature of capsule endoscopes to drive adoption 100
6.2.4 OTHER ENDOSCOPY DEVICES 102
6.3 ABLATION DEVICES 103
6.3.1 RADIOFREQUENCY ABLATION DEVICES 104
6.3.1.1 Low cost of radiofrequency ablation to contribute to market growth 104
6.3.2 MICROWAVE ABLATION DEVICES 106
6.3.2.1 Advantages over RF ablation to ensure sustained demand for microwave ablation devices 106
6.3.3 CRYOABLATION DEVICES 107
6.3.3.1 Increasing cancer incidence to drive market for cryoablation devices 107
6.3.4 LASER ABLATION DEVICES 108
6.3.4.1 High efficacy and safety to drive adoption of laser/light ablation devices 108
6.3.5 OTHER ABLATION DEVICES 110
6.4 MOTILITY TESTING DEVICES 111
6.4.1 ESOPHAGEAL MANOMETRY DEVICES 112
6.4.1.1 Rising incidence of esophageal motility disorders to boost market growth 112
6.4.2 4-HOUR PH IMPEDANCE TESTING DEVICES 114
6.4.2.1 Ability to provide data useful for tailoring individualized treatment plans to favor market growth 114
6.4.3 ANORECTAL MANOMETRY DEVICES 115
6.4.3.1 Growing popularity of anorectal manometry devices for diagnosis of gastrointestinal problems to support market growth 115
6.4.4 OTHER MOTILITY TESTING DEVICES 116
6.5 BIOPSY DEVICES 117
6.5.1 NEEDLE BIOPSY DEVICES 119
6.5.1.1 Increasing screening of gastrointestinal diseases to aid growth 119
6.5.2 OTHER BIOPSY DEVICES 120
6.6 STENTING DEVICES 121
6.6.1 BILIARY STENTS 123
6.6.1.1 Increasing prevalence of bile duct cancer and chronic liver disease to drive growth 123
6.6.2 COLONIC STENTS 126
6.6.2.1 Rising demand for colonic stents due to high incidence of colorectal cancer to drive segmental growth 126
6.6.3 DUODENAL STENTS 127
6.6.3.1 Increasing prevalence of intestinal malignancy to boost adoption of duodenal stents 127
6.6.4 PANCREATIC STENTS 130
6.6.4.1 Rising number of ERCP and PTC procedures to drive market growth 130
6.6.5 ESOPHAGEAL STENTS 132
6.6.5.1 Increasing incidence of esophageal cancer to propel market growth 132
6.7 PH MONITORING DEVICES 133
6.7.1 ESOPHAGEAL PH MONITORING CATHETERS 135
6.7.1.1 Growing sedentary lifestyles to drive demand 135
6.7.2 WIRELESS PH MONITORING CAPSULES 136
6.7.2.1 Reduced risk of open surgeries to boost market 136
6.7.3 AMBULATORY PH MONITORING SYSTEMS 137
6.7.3.1 Convenience and accuracy of ambulatory pH monitoring to drive market 137
6.8 OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES 139
6.8.1 GASTRIC BALLOONS 140
6.8.1.1 Minimally invasive nature of gastric balloons to boost adoption 140
6.8.2 GASTROINTESTINAL TUBES 141
6.8.2.1 Rising incidence of diseases to drive need for gastrointestinal tubes 141
6.8.3 HEMORRHOID TREATMENT DEVICES 143
6.8.3.1 Rising cases of hemorrhoids to support market growth 143
7 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE 144
7.1 INTRODUCTION 145
7.2 GASTROINTESTINAL CANCERS 146
7.2.1 CHANGING DIETS AND GROWING PREVALENCE OF OBESITY TO BOOST MARKET GROWTH 146
7.3 GASTROESOPHAGEAL REFLUX DISEASE 147
7.3.1 GROWING INCIDENCE OF GERD TO DRIVE MARKET GROWTH 147
7.4 IRRITABLE BOWEL SYNDROME (IBS) 149
7.4.1 GROWING IBS DISEASE BURDEN TO DRIVE DEMAND FOR GASTROINTESTINAL PRODUCTS 149
7.5 INFLAMMATORY BOWEL DISEASE (IBD) 150
7.5.1 GROWING USE OF CAPSULE ENDOSCOPES IN TREATING IBD TO FAVOR MARKET GROWTH 150
7.6 OTHER DISEASES 152
8 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER 154
8.1 INTRODUCTION 155
8.2 HOSPITALS 155
8.2.1 HIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL PROCEDURES IN HOSPITALS 155
8.3 AMBULATORY SURGICAL CENTERS & INDEPENDENT SURGICAL CENTERS 157
8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE MARKET GROWTH 157
8.4 CLINICS 158
8.4.1 GROWING NEED FOR CLINICAL SCREENING TO DIAGNOSE GASTROINTESTINAL DISEASES TO BOOST MARKET 158
8.5 OTHER END USERS 160
9 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION 161
9.1 INTRODUCTION 162
9.2 NORTH AMERICA 162
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 164
9.2.2 US 168
9.2.2.1 US to dominate North American market during forecast period 168
9.2.3 CANADA 174
9.2.3.1 Increased availability of funding and presence of research institutes to propel market 174
9.3 EUROPE 179
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 180
9.3.2 GERMANY 184
9.3.2.1 Favorable reimbursement scenario and increased geriatric population to aid market growth 184
?
9.3.3 UK 190
9.3.3.1 Rising investments by hospitals in new and advanced gastroenterology/gastrointestinal products to augment market growth 190
9.3.4 FRANCE 195
9.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth 195
9.3.5 ITALY 200
9.3.5.1 High per capita income and improved healthcare system to drive market 200
9.3.6 SPAIN 205
9.3.6.1 Growing prevalence of cardiovascular diseases to boost market growth 205
9.3.7 REST OF EUROPE 210
9.4 ASIA PACIFIC 215
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 217
9.4.2 JAPAN 222
9.4.2.1 Favorable medical device reimbursement policies and public health insurance schemes to aid market growth 222
9.4.3 CHINA 227
9.4.3.1 Increasing geriatric population and increase in domestic manufacturers for gastrointestinal products to support growth 227
9.4.4 INDIA 232
9.4.4.1 Increasing incidence of diseases like diabetes to enhance market growth 232
9.4.5 AUSTRALIA 236
9.4.5.1 High incidence of cancer to propel market growth 236
9.4.6 SOUTH KOREA 242
9.4.6.1 Rapidly aging population and high incidence of gastrointestinal diseases to aid market growth 242
9.4.7 REST OF ASIA PACIFIC 247
9.5 LATIN AMERICA 252
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 253
9.5.2 BRAZIL 257
9.5.2.1 Increase in private healthcare investments and rise in medical tourism to aid market growth 257
9.5.3 MEXICO 263
9.5.3.1 Increased government investment in healthcare infrastructure and technological advancements to aid market growth 263
9.5.4 REST OF LATIN AMERICA 268
9.6 MIDDLE EAST & AFRICA 272
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 272
9.6.2 GCC COUNTRIES 277
9.6.2.1 Increasing investment in healthcare infrastructure and growing medical tourism to propel market growth 277
9.6.3 REST OF MIDDLE EAST & AFRICA 281
10 COMPETITIVE LANDSCAPE 286
10.1 OVERVIEW 286
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 286
10.3 REVENUE ANALYSIS, 2021–2023 287
10.4 MARKET SHARE ANALYSIS, 2023 288
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 290
10.5.1 STARS 291
10.5.2 EMERGING LEADERS 291
10.5.3 PERVASIVE PLAYERS 291
10.5.4 PARTICIPANTS 291
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 293
10.5.5.1 Company footprint 293
10.5.5.2 Disease footprint 294
10.5.5.3 End-user footprint 295
10.5.5.4 Region footprint 296
10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 296
10.6.1 PROGRESSIVE COMPANIES 296
10.6.2 RESPONSIVE COMPANIES 296
10.6.3 DYNAMIC COMPANIES 297
10.6.4 STARTING BLOCKS 297
10.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023 298
10.7 COMPETITIVE SCENARIO 299
10.7.1 PRODUCT LAUNCHES & APPROVALS 299
10.7.2 DEALS 301
10.7.3 EXPANSIONS 303
10.8 BRAND/PRODUCT COMPARISON 304
10.9 COMPANY VALUATION & FINANCIAL METRICS 304
10.9.1 FINANCIAL METRICS 304
10.9.2 COMPANY VALUATION 305
11 COMPANY PROFILES 306
11.1 KEY PLAYERS 306
11.1.1 OLYMPUS CORPORATION 306
11.1.1.1 Business overview 306
11.1.1.2 Products offered 307
11.1.1.3 Recent developments 309
11.1.1.3.1 Product launches & approvals 309
11.1.1.3.2 Deals 310
11.1.1.3.3 Expansions 311
11.1.1.4 MnM view 313
11.1.1.4.1 Right to win 313
11.1.1.4.2 Strategic choices 313
11.1.1.4.3 Weaknesses & competitive threats 313
11.1.2 BOSTON SCIENTIFIC CORPORATION 314
11.1.2.1 Business overview 314
11.1.2.2 Products offered 315
11.1.2.3 Recent developments 317
11.1.2.3.1 Product launches & approvals 317
11.1.2.3.2 Deals 318
11.1.2.4 MnM view 318
11.1.2.4.1 Right to win 318
11.1.2.4.2 Strategic choices 319
11.1.2.4.3 Weaknesses & competitive threats 319
11.1.3 MEDTRONIC PLC 320
11.1.3.1 Business overview 320
11.1.3.2 Products offered 321
11.1.3.3 Recent developments 323
11.1.3.3.1 Product approvals 323
11.1.3.3.2 Deals 324
11.1.3.4 MnM view 324
11.1.3.4.1 Right to win 324
11.1.3.4.2 Strategic choices 324
11.1.3.4.3 Weaknesses & competitive threats 324
11.1.4 STRYKER CORPORATION 325
11.1.4.1 Business overview 325
11.1.4.2 Products offered 326
11.1.4.3 Recent developments 327
11.1.4.3.1 Product approvals 327
11.1.4.3.2 Deals 327
11.1.4.3.3 Expansions 328
11.1.4.4 MnM view 328
11.1.4.4.1 Right to win 328
11.1.4.4.2 Strategic choices 328
11.1.4.4.3 Weaknesses & competitive threats 328
11.1.5 COOK MEDICAL 329
11.1.5.1 Business overview 329
11.1.5.2 Products offered 330
11.1.5.3 Recent developments 331
11.1.5.3.1 Product launches & approvals 331
11.1.5.3.2 Deals 332
11.1.5.4 MnM view 333
11.1.5.4.1 Right to win 333
11.1.5.4.2 Strategic choices 333
11.1.5.4.3 Weaknesses & competitive threats 333
11.1.6 FUJIFILM CORPORATION 334
11.1.6.1 Business overview 334
11.1.6.2 Products offered 336
11.1.6.3 Recent developments 337
11.1.6.3.1 Product launches & approvals 337
11.1.6.3.2 Other developments 338
11.1.7 CONMED CORPORATION 339
11.1.7.1 Business overview 339
11.1.7.2 Products offered 341
11.1.8 ETHICON (A JOHNSON & JOHNSON SUBSIDIARY) 342
11.1.8.1 Business overview 342
11.1.8.2 Products offered 343
11.1.8.3 Recent developments 344
11.1.8.3.1 Product launches & approvals 344
11.1.9 MERIT MEDICAL SYSTEMS 345
11.1.9.1 Business overview 345
11.1.9.2 Products offered 347
11.1.9.3 Recent developments 348
11.1.9.3.1 Product launches 348
11.1.10 STERIS PLC 349
11.1.10.1 Business overview 349
11.1.10.2 Products offered 350
11.1.11 KARL STORZ SE & CO. KG 352
11.1.11.1 Business overview 352
11.1.11.2 Products offered 353
11.1.11.3 Recent developments 354
11.1.11.3.1 Deals 354
11.2 OTHER PLAYERS 355
11.2.1 SHAILI ENDOSCOPY 355
11.2.2 TAEWOONG MEDICAL CO., LTD. 356
11.2.3 HOBBS MEDICAL, INC. 357
11.2.4 PENTAX MEDICAL 358
11.2.5 ERBE ELEKTROMEDIZIN 359
11.2.6 AMBU A/S 360
11.2.7 CAPSOVISION, INC. 361
11.2.8 INTROMEDIC, INC. 361
11.2.9 VIMEX ENDOSCOPY 362
11.2.10 TRIVITRON HEALTHCARE 362
11.2.11 MEDI-GLOBE CORPORATION 363
11.2.12 SONOSCAPE MEDICAL CORP. 363
11.2.13 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD. 364
11.2.14 MEDSPIRA 364
12 APPENDIX 365
12.1 DISCUSSION GUIDE 365
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 371
12.3 CUSTOMIZATION OPTIONS 373
12.4 RELATED REPORTS 373
12.5 AUTHOR DETAILS 374



List of Figures

FIGURE 1 RESEARCH DESIGN 38
FIGURE 2 PRIMARY SOURCES 42
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE DESIGNATION, AND REGION 44
FIGURE 4 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 45
FIGURE 5 TOP-DOWN APPROACH 46
FIGURE 6 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT 47
FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029): IMPACT LEVEL OF CAGR 48
FIGURE 8 CAGR PROJECTIONS 48
FIGURE 9 DATA TRIANGULATION METHODOLOGY 50
FIGURE 10 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DEVICE, 2024 VS. 2029 (USD MILLION) 52
FIGURE 11 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2024 VS. 2029 (USD MILLION) 53
FIGURE 12 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2024 VS. 2029 (USD MILLION) 53
FIGURE 13 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
ENDOSCOPY DEVICES, BY TYPE, 2024 VS. 2029 (USD MILLION) 54
FIGURE 14 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
GEOGRAPHIC SNAPSHOT 55
FIGURE 15 INCREASING PREVALENCE OF GI DISORDERS TO DRIVE MARKET GROWTH 56
FIGURE 16 ENDOSCOPY DEVICES ACCOUNTED FOR LARGEST SHARE OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET IN 2023 57
FIGURE 17 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 58
FIGURE 18 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
FIGURE 19 ADVANCEMENTS IN TECHNOLOGY, FOCUS ON PREVENTIVE CARE AND SHIFT TOWARD PATIENT-CENTERED APPROACHES 66
FIGURE 20 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
VALUE CHAIN ANALYSIS 68
FIGURE 21 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
PORTER’S FIVE FORCE ANALYSIS 69
FIGURE 22 GLOBAL NUMBER OF PATENT PUBLICATIONS (JANUARY 2014–MARCH 2024) 77
FIGURE 23 TOP APPLICANT & OWNER (COMPANIES/INSTITUTIONS) PATENTS
(JANUARY 2014–MARCH 2024) 77
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS 84
FIGURE 25 KEY BUYING CRITERIA FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS 85
FIGURE 26 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
ECOSYSTEM ANALYSIS 88
FIGURE 27 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
SUPPLY CHAIN ANALYSIS 90
FIGURE 28 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: INVESTMENT & FUNDING SCENARIO, 2018–2023 91
FIGURE 29 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL
PRODUCTS MARKET SNAPSHOT 163
FIGURE 30 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL
PRODUCTS MARKET SNAPSHOT 216
FIGURE 31 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET 287
FIGURE 32 REVENUE ANALYSIS FOR KEY PLAYERS IN GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET (2019–2023) 288
FIGURE 33 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GASTROENTEROLOGY/ GASTROINTESTINAL PRODUCTS MARKET (2023) 289
FIGURE 34 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 292
FIGURE 35 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY FOOTPRINT 293
FIGURE 36 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023 297
FIGURE 37 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
BRAND/PRODUCT COMPARATIVE ANALYSIS 304
FIGURE 38 EV/EBITDA OF KEY VENDORS 304
FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 305
FIGURE 40 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2023) 307
FIGURE 41 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023) 315
FIGURE 42 MEDTRONIC PLC: COMPANY SNAPSHOT (2023) 321
FIGURE 43 STRYKER CORPORATION: COMPANY SNAPSHOT (2023) 326
FIGURE 44 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2023) 335
FIGURE 45 CONMED CORPORATION: COMPANY SNAPSHOT (2023) 340
FIGURE 46 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2023) 343
FIGURE 47 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2023) 346
FIGURE 48 STERIS PLC: COMPANY SNAPSHOT (2023) 350

List of Tables

TABLE 1 STANDARD CURRENCY CONVERSION RATES 35
TABLE 2 GLOBAL HEALTHCARE EXPENDITURES, BY REGION, 2022–2023 62
TABLE 3 ASIA PACIFIC: HEALTHCARE EXPENDITURE, BY COUNTRY, 2022–2023 63
TABLE 4 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 69
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 74
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 74
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 75
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 75
TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 76
TABLE 10 HS CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS 78
TABLE 11 IMPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019–2023 (USD THOUSAND) 79
TABLE 12 EXPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019–2023 (USD THOUSAND) 79
TABLE 13 AVERAGE SELLING PRICE OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS, BY KEY PLAYER, 2023 (USD) 80
TABLE 14 AVERAGE SELLING PRICE OF GASTROINTESTINAL PRODUCTS, BY REGION 2021–2023 81
TABLE 15 REIMBURSEMENT CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL PROCEDURES 82
TABLE 16 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
KEY CONFERENCES & EVENTS, 2024–2025 83
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS 84
TABLE 18 KEY BUYING CRITERIA FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS 85
TABLE 19 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: UNMET NEEDS 86
TABLE 20 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: END-USER EXPECTATIONS 87
TABLE 21 CASE STUDY 1: AI-ENHANCED CAPSULE ENDOSCOPY FOR SMALL BOWEL
DISEASE DETECTION 89
TABLE 22 CASE STUDY 2: RADIOFREQUENCY ABLATION FOR BARRETT’S ESOPHAGUS 89
TABLE 23 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: AI INTEGRATION 92
TABLE 24 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION) 95
TABLE 25 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 96
TABLE 26 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (THOUSAND UNITS) 96
TABLE 27 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 28 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION) 99
TABLE 29 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 30 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CAPSULE ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION) 101
TABLE 31 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ENDOSCOPY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 102
TABLE 32 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 103
TABLE 33 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, VOLUME DATA 2022–2029 (THOUSAND UNITS) 103
TABLE 34 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 35 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 105
TABLE 36 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MICROWAVE ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 37 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CRYOABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 38 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR LASER ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 109
TABLE 39 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 40 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 111
TABLE 41 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 112
TABLE 42 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL MANOMETRY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 43 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR 4-HOUR PH IMPEDANCE TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 44 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ANORECTAL MANOMETRY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 45 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER MOTILITY TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 46 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 118
TABLE 47 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 48 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR NEEDLE BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 49 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR OTHER BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 50 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 122
TABLE 51 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (THOUSAND UNITS) 122
TABLE 52 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 53 BILIARY STENTS OFFERED BY PROMINENT PLAYERS 124
TABLE 54 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BILIARY STENTS, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 55 COLONIC STENTS OFFERED BY PROMINENT PLAYERS 126
TABLE 56 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR COLONIC STENTS, BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 57 DUODENAL STENTS OFFERED BY PROMINENT PLAYERS 128
TABLE 58 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR DUODENAL STENTS, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 59 PANCREATIC STENTS OFFERED BY PROMINENT PLAYERS 130
TABLE 60 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PANCREATIC STENTS, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 61 ESOPHAGEAL STENTS OFFERED BY PROMINENT PLAYERS 132
TABLE 62 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL STENTS, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 63 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 134
TABLE 64 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 65 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL PH MONITORING CATHETERS, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 66 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR WIRELESS PH MONITORING CAPSULES, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 67 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY PH MONITORING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 68 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 139
TABLE 69 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY COUNTRY 2022–2029 (USD MILLION) 140
TABLE 70 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTRIC BALLOONS, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 71 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL TUBES, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 72 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HEMORRHOID TREATMENT DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 73 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 145
TABLE 74 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL CANCERS, BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 75 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD), BY COUNTRY 2022–2029 (USD MILLION) 148
TABLE 76 TYPES OF IBS WITH SEVERITY INDEX 149
TABLE 77 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR IRRITABLE BOWEL SYNDROME (IBS), BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 78 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR INFLAMMATORY BOWEL DISEASE (IBD), BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 79 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 80 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2022–2029 (USD MILLION) 155
TABLE 81 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 82 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY SURGICAL CENTERS & INDEPENDENT DIAGNOSTIC CENTERS, BY COUNTRY 2022–2029 (USD MILLION) 158
TABLE 83 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CLINICS BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 84 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 85 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION) 162
TABLE 86 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 87 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION) 164
TABLE 88 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 89 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 90 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 91 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 92 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 93 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 167
TABLE 94 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION) 167
TABLE 95 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION) 167
TABLE 96 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 168
TABLE 97 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2024 169
TABLE 98 LIST OF DEVICES THAT RECEIVED FDA APPROVALS BETWEEN 2020 AND 2023 169
TABLE 99 US: MACROECONOMIC INDICATORS 170
TABLE 100 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION) 170
TABLE 101 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 171
TABLE 102 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 171
TABLE 103 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 171
TABLE 104 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 172
TABLE 105 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 172
TABLE 106 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 172
TABLE 107 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 173
TABLE 108 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 173
TABLE 109 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2022–2029 (USD MILLION) 174
TABLE 110 CANADA: MACROECONOMIC INDICATORS 175
TABLE 111 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DEVICE, 2022–2029 (USD MILLION) 175
TABLE 112 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 113 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 114 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 177
TABLE 115 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 177
TABLE 116 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 177
TABLE 117 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 118 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 178
TABLE 119 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 179
TABLE 120 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2022–2029 (USD MILLION) 179
TABLE 121 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DEVICE, 2022–2029 (USD MILLION) 180
TABLE 122 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 180
TABLE 123 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 124 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 125 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 126 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 127 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 128 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 183
TABLE 129 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 183
TABLE 130 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2022–2029 (USD MILLION) 184
TABLE 131 GERMANY: MACROECONOMIC INDICATORS 185
TABLE 132 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DEVICE, 2022–2029 (USD MILLION) 185
TABLE 133 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 186
TABLE 134 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 186
TABLE 135 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 136 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 137 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 138 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 139 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 188
TABLE 140 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 189
TABLE 141 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2022–2029 (USD MILLION) 189
TABLE 142 UK: MACROECONOMIC INDICATORS 190
TABLE 143 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION) 191
TABLE 144 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 145 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 146 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 147 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 148 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 193
TABLE 149 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 193
TABLE 150 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 194
TABLE 151 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 194
TABLE 152 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2022–2029 (USD MILLION) 195
TABLE 153 FRANCE: MACROECONOMIC INDICATORS 196
TABLE 154 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DEVICE, 2022–2029 (USD MILLION) 196
TABLE 155 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 156 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 157 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 158 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 159 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 160 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 161 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 199
TABLE 162 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 199
TABLE 163 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2022–2029 (USD MILLION) 200
TABLE 164 ITALY: MACROECONOMIC INDICATORS 201
TABLE 165 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION) 201
TABLE 166 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 167 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 168 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 169 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 170 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 171 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 172 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 204
TABLE 173 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 205
TABLE 174 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2022–2029 (USD MILLION) 205
TABLE 175 SPAIN: MACROECONOMIC INDICATORS 206
TABLE 176 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DEVICE, 2022–2029 (USD MILLION) 206
TABLE 177 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 207
TABLE 178 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 207
TABLE 179 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 180 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 181 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 182 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 183 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 209
TABLE 184 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 210
TABLE 185 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2022–2029 (USD MILLION) 210
TABLE 186 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION) 211
TABLE 187 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 188 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 189 REST OF EUROPE: : GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 190 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 191 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 192 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 193 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 194 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION) 215
TABLE 195 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 215
TABLE 196 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 217
TABLE 197 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DEVICE, 2022–2029 (USD MILLION) 217
TABLE 198 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 199 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 200 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 201 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 202 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 203 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 204 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 220
TABLE 205 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 221
TABLE 206 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2022–2029 (USD MILLION) 221
TABLE 207 JAPAN: MACROECONOMIC INDICATORS 222
TABLE 208 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DEVICE, 2022–2029 (USD MILLION) 223
TABLE 209 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 223
TABLE 210 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 211 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 212 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 213 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 225
TABLE 214 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 225
TABLE 215 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 225
TABLE 216 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 226
TABLE 217 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY END USER, 2022–2029 (USD MILLION) 226
TABLE 218 CHINA: MACROECONOMIC INDICATORS 227
TABLE 219 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DEVICE, 2022–2029 (USD MILLION) 228
TABLE 220 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 228
TABLE 221 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 222 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 223 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 224 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 225 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 226 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE 2022–2029 (USD MILLION) 231
TABLE 227 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET BY DISEASE, 2022–2029 (USD MILLION) 231
TABLE 228 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MAR